COPENHAGEN, Denmark, 27 March 2025

DanCann Pharma A/S’ annual report 2024 was planned to be released on 31 March 2025, and the annual general meeting 2025 was planned to be held on 14 April 2025.

The release of the annual report 2024, the notice of the annual general meeting 2025 and the holding of the annual general meeting 2025 are postponed to the following dates:

DanCann Pharma A/S’ financial calendar has been updated accordingly.

For further information, please contact:

Jeppe Krog Rasmussen, CEO

E-mail: jkr@dancann.com

About DanCann Pharma A/S

DanCann Pharma A/S (SS: DANCAN) was founded in 2018 and is a Danish biopharmaceutical Company powered by cannabinoids.

DanCann Pharma A/S (SS: DANCAN) is listed on the Spotlight Stock Market in Copenhagen/Stockholm.

For more information, visit: www.dancann.com